JP2025515096A5 - - Google Patents
Info
- Publication number
- JP2025515096A5 JP2025515096A5 JP2024564931A JP2024564931A JP2025515096A5 JP 2025515096 A5 JP2025515096 A5 JP 2025515096A5 JP 2024564931 A JP2024564931 A JP 2024564931A JP 2024564931 A JP2024564931 A JP 2024564931A JP 2025515096 A5 JP2025515096 A5 JP 2025515096A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- halogen
- halogenated
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263338181P | 2022-05-04 | 2022-05-04 | |
| US63/338,181 | 2022-05-04 | ||
| PCT/US2023/066533 WO2023215775A1 (en) | 2022-05-04 | 2023-05-03 | Pyridone compounds as trpa1 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515096A JP2025515096A (ja) | 2025-05-13 |
| JP2025515096A5 true JP2025515096A5 (cg-RX-API-DMAC7.html) | 2026-05-11 |
Family
ID=88647177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024564931A Pending JP2025515096A (ja) | 2022-05-04 | 2023-05-03 | Trpa1阻害剤としてのピリドン化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250270198A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4519250A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025515096A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119451948A (cg-RX-API-DMAC7.html) |
| AR (1) | AR129212A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3250397A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202400148A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023215775A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025167992A1 (zh) * | 2024-02-08 | 2025-08-14 | 宜昌人福药业有限责任公司 | 一种非选择性阳离子通道trpa1拮抗剂及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017060488A1 (en) * | 2015-10-09 | 2017-04-13 | Almirall, S.A. | New trpa1 antagonists |
| WO2022056042A1 (en) * | 2020-09-09 | 2022-03-17 | University Of Virginia Patent Foundation | Inhibitors of spinster homolog 2 (spns2) for use in therapy |
| CA3211048A1 (en) * | 2021-04-14 | 2022-10-20 | Boehringer Ingelheim International Gmbh | 3h,4h,5h,6h,7h-pyrimido[4,5-b][1,4]oxazine-4,6-dione derivatives as trpa1 inhibitors |
| US20250136587A1 (en) * | 2022-02-03 | 2025-05-01 | D. E. Shaw Research, Llc | N3-substituted uracil compounds as trpa1 inhibitors |
-
2023
- 2023-05-03 WO PCT/US2023/066533 patent/WO2023215775A1/en not_active Ceased
- 2023-05-03 TW TW112116368A patent/TW202400148A/zh unknown
- 2023-05-03 JP JP2024564931A patent/JP2025515096A/ja active Pending
- 2023-05-03 AR ARP230101074A patent/AR129212A1/es unknown
- 2023-05-03 US US18/862,249 patent/US20250270198A1/en active Pending
- 2023-05-03 EP EP23800196.0A patent/EP4519250A4/en active Pending
- 2023-05-03 CA CA3250397A patent/CA3250397A1/en active Pending
- 2023-05-03 CN CN202380048290.4A patent/CN119451948A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025506372A5 (cg-RX-API-DMAC7.html) | ||
| US6218397B1 (en) | Pyrazolopyrimidines as CRF antagonists | |
| JP2025506422A5 (cg-RX-API-DMAC7.html) | ||
| DE69711430T2 (de) | PYRROLO[3,4-d]PYRIMIDINON-DERIVATE UND IHRE VERWENDUNG ALS IMMUNOSUPPRESSOREN | |
| WO1995028387A1 (en) | Benzamide compound and medicinal use thereof | |
| RU2007146798A (ru) | ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА | |
| JP2010540508A5 (cg-RX-API-DMAC7.html) | ||
| CA2665476A1 (en) | Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors | |
| US5063227A (en) | Quinazoline-substituted pyridazinone derivatives having cardiotonic activity | |
| SK83594A3 (en) | Imidazole derivatives, method of their preparation, their use for production of pharmaceutical compositions with their contents | |
| JP2013526494A5 (cg-RX-API-DMAC7.html) | ||
| SK135699A3 (en) | Pyrazolo[3,4-d]pyrimidinedione compounds, preparation method thereof, pharmaceutical composition containing them and their use | |
| KR102428882B1 (ko) | 카이네이즈 저해제로서의 피롤로트리아진 유도체 | |
| IL235097A (en) | History of insulin-2 and as protein kinase inhibitors | |
| SK278310B6 (en) | Alpha-aryl-4-/4,5-dihydro-3,5-dioxo-1,2,4-triazine- -2(3h)yl/benzeneacetonitriles and manufacturing process thereof | |
| JPH06228108A (ja) | フタラジノン誘導体 | |
| DE69115744T2 (de) | Konjugate von Difluoroglutaminsäure mit Fölaten und Antifölaten für die Behandlung von neoplastischen Krankheiten | |
| JP7618642B2 (ja) | インターロイキンの調節におけるプロドラッグ | |
| EP2632916B1 (en) | Novel anti-cancer agents | |
| DE69226703T2 (de) | Imidazo (4,5-c)pyridinderivate als paf antagonisten | |
| US4711883A (en) | Substituted 3-(4-phenyl-1-piperazinyl)alkylquinazolin-2,4-(1H,3H) diones, methods of preparation, compositions and method of use | |
| US7750049B2 (en) | O-substituted-dibenzyl urea-derivatives as TRPV1 receptor antagonists | |
| US8202899B2 (en) | Pyrazole urea derivatives used as kinase inhibitors | |
| JPH0196180A (ja) | ベンゾイミダゾール化合物、その製造法およびこれらの化合物を含有する心機能不全治療用組成物 | |
| KR20240007619A (ko) | 포스포리파제 d 억제제로서의 신규 화합물 및 이의용도 |